Skip to main content
HR 3793 118th Congress House Health Civil actions and liability Consumer affairs Government information and archives Prescription drugs

Ensuring Access to Lifesaving Drugs Act of 2023

Introduced: July 26, 2023 Introduced by: Slotkin, Elissa Democratic · Michigan See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 9, 2023
Referred to the Subcommittee on Health.
Jun 5, 2023
Referred to the House Committee on Energy and Commerce.
Jun 5, 2023
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Ensuring Access to Lifesaving Drugs Act of 2023

This bill allows the Food and Drug Administration (FDA) to obtain additional information from manufacturers of life-saving drugs in order to assess and potentially modify the drug's expiration date. (The bill defines life-saving drug as a medical countermeasure or a drug that is in short supply and that is life-supporting, life-sustaining, or intended to be used to prevent or treat a debilitating disease or condition in humans or animals.)

Specifically, the FDA may order a manufacturer of a life-saving drug to submit data and other information from any stage of the drug's development in order to assess the drug's stability and the longest supported expiration date. If such information is not readily available, the FDA may order the manufacturer to conduct additional studies. The FDA may require changes to the drug's label accordingly. Manufacturers that fail to comply are subject to civil penalties. 

 

What's happening now June 9, 2023

Referred to the Subcommittee on Health.

 Related & companion bills 1
  • HR 4697 Related bill Protecting PAHPA Act of 2023
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 2
All 2 Democratic 1
D
Peters, Scott H.
California · Jul 26, 2023
Sarbanes, John
· Jul 26, 2023
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 3793: Ensuring Access to Lifesaving Drugs Act of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-HR-3793/
MLA
"H.R. 3793: Ensuring Access to Lifesaving Drugs Act of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-3793/.
Bluebook (legal)
H.R. 3793, 118th Cong. (2026), https://openamerica.io/bill/118-HR-3793/.
Markdown link
[H.R. 3793: Ensuring Access to Lifesaving Drugs Act of 2023](https://openamerica.io/bill/118-HR-3793/)
Report a problem